ADHD as an Autism Comorbidity Within Kitzerow’s Autism and the Comorbidities Theoretical Mode
Autism and the Comorbidities Theory
ADHD as an Autism Comorbidity in Kitzerow's Autism and the Comorbidities Theoretical Model
A systems biology framework explaining how impairments in stress-response regulation, catecholamine turnover, and restoration of physiological set points may contribute to ADHD and its overlap with autism.
Key Concept
ADHD as a Regulatory Comorbidity
ADHD is commonly described as an attention-based disorder. Within Kitzerow's Autism and the Comorbidities Theoretical Model, ADHD is proposed to involve impairments in the regulation and turnover phases of the stress response that leave fight, flight, freeze, or fawn responses active for longer than is typical after activation.
In this model, the immediate stress response is not the primary impairment. Stored catecholamines can still be rapidly released from synaptic vesicles when physiological set points are breached. The proposed impairment occurs after activation, when the body must regulate catecholamine signaling, metabolize neurotransmitters, restore physiological set points, and return to baseline.
ADHD Overview
What ADHD Looks Like
ADHD is a neurodevelopmental condition associated with differences in attention regulation, executive functioning, impulsivity, activity level, emotional regulation, and task persistence. These characteristics vary widely between individuals and may change depending on biological state, environment, stress load, sleep, sensory input, and developmental stage.
This page does not replace the clinical description of ADHD. It offers a proposed systems-level explanation for why ADHD characteristics may occur and why ADHD commonly co-occurs with autism.
Executive Function
ADHD may affect initiation, planning, organization, task switching, working memory, follow-through, and flexible problem solving.
Behavioral Regulation
ADHD may involve impulsivity, hyperactivity, restlessness, difficulty inhibiting responses, and difficulty maintaining goal-directed behavior.
Emotional Regulation
ADHD may involve frustration intolerance, emotional reactivity, rejection sensitivity, shutdown, avoidance, or rapid shifts in state.
Stress Response System
The Stress Response as a Regulatory System
The fight, flight, freeze, and fawn response is a regulatory system. It activates when internal or external demands breach physiological set points. The purpose of the response is not simply to react. Its purpose is to restore regulation and return the body to baseline.
If physiological set points are restored efficiently, the response resolves. If physiological set points remain dysregulated, the response may persist.
Stress-Response Sequence
Phase 1
Activation
Activation begins when physiological set points are breached. This may occur in response to an external demand, social threat, sensory overload, uncertainty, frustration, pain, fatigue, metabolic stress, or another internal or external stressor.
Physiological Set Point Breach
A set point breach means the body detects that one or more physiological variables have moved outside their target range. The stress response activates to protect the organism and restore regulation.
Immediate Catecholamine Release
The immediate fight, flight, freeze, or fawn response is produced by catecholamines that have already been synthesized and stored inside synaptic vesicles. When activation occurs, these stored catecholamines are rapidly released.
This distinction matters. The model does not propose that low dopamine prevents the stress response from activating. It proposes that impairments after activation may make the response harder to regulate and resolve.
Phase 2
Regulation and Turnover
Once activated, the stress response becomes a continuously regulated biological process. Catecholamine synthesis, receptor signaling, breakdown, turnover, and physiological feedback occur at the same time.
The response remains active while physiological set points remain outside their target ranges. Regulation is the process by which the body attempts to restore those set points.
Catecholamine Synthesis
Dopamine is synthesized from tyrosine through a BH4-dependent pathway. Dopamine also serves as the biochemical precursor to norepinephrine and epinephrine.
During an activated stress response, catecholamines continue to be synthesized to support signaling and replenish neurotransmitter stores.
Catecholamine Signaling
Catecholamines act through dopamine receptors and adrenergic receptors to coordinate physiological and behavioral responses. These signals influence arousal, movement, vigilance, inhibition, emotional intensity, and response selection.
Breakdown and Turnover
Catecholamines are continuously metabolized while the stress response is active. Breakdown and turnover help control the duration and intensity of signaling.
MAOA contributes to catecholamine turnover through oxidative deamination. This helps terminate neurotransmitter signaling and supports continued turnover.
COMT transfers a methyl group to catecholamines. This contributes to catecholamine inactivation and influences the rate at which they are metabolized and cleared.
Variants affecting MAOA or COMT may alter stress-response kinetics by changing how long catecholamine signaling persists.
Physiological Feedback
Physiological feedback systems monitor whether set points have been restored. If set points remain outside their target ranges, regulatory activity continues.
In this framework, persistent fight, flight, freeze, or fawn states are understood as regulatory system states that remain active because baseline has not yet been efficiently restored.
Phase 3
Return to Baseline
The stress response resolves when physiological set points are restored. Returning to baseline depends on coordinated regulation of catecholamine synthesis, vesicular release, receptor signaling, MAOA activity, COMT activity, and physiological feedback.
Core Mechanistic Point
Within this model, ADHD is proposed to involve impairments in regulation and turnover that leave fight, flight, freeze, or fawn responses active for longer than is typical after activation.
Theoretical Model
ADHD Within Kitzerow's Autism and the Comorbidities Theoretical Model
Within Kitzerow's Autism and the Comorbidities Theoretical Model, ADHD is proposed to involve impairments in the regulation and turnover phases of the stress response rather than the activation phase.
The immediate response remains intact because catecholamines are rapidly released from synaptic vesicles when physiological set points are breached. Once activated, however, the stress response depends on ongoing catecholamine synthesis, receptor signaling, neurotransmitter turnover, and physiological feedback to restore baseline.
Central Thesis
ADHD is proposed to reflect a stress-response state that remains active longer than is typical because regulation and turnover are not efficiently restoring physiological set points after activation.
Not an Activation Deficit
The model does not propose that the body cannot activate the stress response. Activation can occur through catecholamines already stored in vesicles.
A Regulation and Turnover Problem
The proposed impairment occurs after activation, when the body must regulate neurotransmitter signaling, metabolize catecholamines, restore set points, and return to baseline.
Autism Comorbidity Mechanism
How the BH4 Shunt Fits
Within this theoretical model, the BH4 shunt represents one pathway that may impair stress-response regulation. BH4 is required for dopamine synthesis. Dopamine is also a precursor to norepinephrine and epinephrine, making dopamine availability important for catecholamine replenishment during an activated stress response.
The BH4 shunt is not proposed to prevent the immediate stress response. Instead, it is proposed to reduce the efficiency of regulation after activation by limiting dopamine availability and downstream catecholamine replenishment.
BH4 Shunt Pathway Within ADHD Comorbidity
Comorbidity
Why ADHD Commonly Co-occurs With Autism
Within this model, ADHD commonly co-occurs with autism because the BH4 shunt may reduce dopamine synthesis, affecting the catecholamine regulation needed to return to baseline after stress-response activation.
BH4 and Dopamine Synthesis
BH4 is required for dopamine synthesis. If BH4 availability is redirected through the BH4 shunt, dopamine synthesis may become less efficient.
Dopamine as a Catecholamine Precursor
Dopamine is not only a neurotransmitter. It is also the biochemical precursor to norepinephrine and epinephrine, which help coordinate the stress response.
ADHD as a Comorbidity
When dopamine synthesis is reduced, catecholamine replenishment during the regulation phase may become less efficient. This may leave fight, flight, freeze, or fawn responses active longer than is typical, contributing to ADHD as an autism comorbidity.
Independent Pathways
Why ADHD Can Also Occur Independently
The BH4 shunt is one pathway, not the only pathway. ADHD can also arise through mechanisms that affect catecholamine regulation without producing the full autism cascade.
Synthesis Pathways
Differences in dopamine synthesis, tyrosine hydroxylase activity, BH4 availability, or related biochemical pathways may affect catecholamine replenishment.
Metabolism Pathways
MAOA and COMT variants may alter catecholamine breakdown, turnover, and clearance, changing the duration and intensity of signaling.
Signaling Pathways
Dopamine receptors, adrenergic receptors, transporters, and downstream signaling pathways may alter how catecholamine signals are interpreted.
Feedback Pathways
Physiological feedback systems may fail to restore set points efficiently, allowing the stress response to persist even after the triggering demand has passed.
Model Summary
The BH4 shunt explains one pathway linking autism and ADHD. Regulation and turnover provide the broader framework that explains both their frequent comorbidity and ADHD's ability to occur independently.
Stress-Response Phenotypes
Fight, Flight, Freeze, and Fawn in ADHD
Within this theoretical model, ADHD characteristics may reflect stress-response states that remain active longer than is typical after activation. PDA and rejection-sensitive dysphoria are presented here as related phenotype profiles, not definitive classifications.
| Stress Response | Common ADHD Presentation | Related Phenotype Profile | Possible Examples |
|---|---|---|---|
| Fight | Impulsivity, emotional outbursts, irritability | PDA-related profile | Arguing, explosive frustration, controlling the environment, refusing demands |
| Flight | Hyperactivity, restlessness, task switching | PDA-related profile | Pacing, leaving demands, constant movement, distraction seeking |
| Freeze | Cognitive shutdown, task paralysis, mental blankness | RSD-related profile | Difficulty initiating tasks, withdrawal, shutdown after criticism |
| Fawn | Masking, perfectionism, people pleasing | RSD-related profile | Over-apologizing, over-accommodating others, fear of disappointing people |
Important Nuance
These profiles are not mutually exclusive. One person may shift between fight, flight, freeze, and fawn depending on context, biological state, developmental history, and environmental demands.
BioToggle®
Regulatory System Considerations
BioToggle® organizes ADHD-related mechanisms by regulatory system rather than treating ADHD as a single pathway. Different systems may influence stress-response kinetics, catecholamine regulation, and restoration of physiological set points.
Nervous System
Catecholamine signaling, dopamine receptors, adrenergic receptors, arousal, executive functioning, and stress-response regulation.
Metabolism
BH4 availability, dopamine synthesis, catecholamine replenishment, energy availability, and metabolic support for regulation.
Immune System
Inflammation, neuroimmune activation, allostatic load, and immune signaling that may alter stress-response regulation.
Cellular Repair
Oxidative stress, redox balance, cellular recovery, and the biological cost of prolonged activation.
Genetic Regulation
Genes affecting synthesis, receptor signaling, catecholamine breakdown, turnover, and feedback regulation, including BH4 pathway genes, MAOA, COMT, dopamine receptors, and adrenergic receptors.
BioToggle® Summary
ADHD may emerge when one or more regulatory systems impair the body's ability to restore physiological baseline after stress-response activation.
Autism and the Comorbidities Theory
The outcomes of the model
Autism aligns with the genetic domain, while neurodivergent traits and comorbidities emerge across other domains based on activation patterns.
Where to Start
Choose the path that matches what you are looking for.
Review the Evidence
Full framework, methodology, validation, and supporting data.
Start Here → ParentsSupport Your Child
Understand development, learning, and practical application.
Start Here → EducatorsTransform Instruction
Apply neuroplasticity-based teaching to build skills and behavior.
Start Here → NeurodivergentsNeurodivergent Biochemistry
See how the model explains development, function, and experience.
Start Here →Common Questions About the Model
These questions break down the model step by step, from core concepts to mechanisms, outcomes, and evidence.
What is this theory, simplified?
Autism and comorbid traits arise from the same upstream biochemical shift. That shift alters development and function in predictable ways, producing both autism traits and comorbid patterns.
Why does the model link autism and comorbidities?
Because they co-occur at high rates. That level of co-occurrence suggests a shared underlying mechanism rather than unrelated conditions.
Is there one single cause of autism?
No. Each individual has a unique combination of genetic and epigenetic factors, but those factors converge on the same stress-response system.
Core Mechanism Questions
These questions define the central biochemical regulators used in the model and clarify how BH4 is positioned within broader cross-system pathway control.
What is BH4?
BH4 is a cofactor that acts as a regulatory molecule across critical biological pathways. It supports neurotransmitter synthesis, impacting mental health and autonomic regulation; nitric oxide signaling, influencing immune function and genetic and epigenetic regulation; and ether lipid catabolism, affecting the endocannabinoid system. Together, these pathways link multiple systems through shared biochemical regulation. Because of this, changes in BH4 availability can produce coordinated effects across both neural development and systemic function.
What is the BH4 Shunt?
The BH4 Shunt describes the redirection of BH4-dependent pathway activity under stress, shifting how biological resources are allocated across systems.
What are redox-sensitive protein shunts?
These are regulatory effectors that alter protein function based on cellular conditions, shifting pathway activity across systems.
Pathway Logic Questions
These questions explain why specific BH4-dependent pathways are prioritized in the model and how pathway shifts affect development, regulation, and comorbidity formation.
Why does the theory focus on AAAH, NOS, and AGMO?
These pathways are the primary BH4-dependent pathways and are not utilized in other regulatory contexts. AAAH governs neurotransmitter synthesis, NOS regulates nitric oxide signaling and redox balance, and AGMO controls ether lipid metabolism and endocannabinoid-related processes. Because all three depend on BH4, shifts in BH4 availability simultaneously alter activity across multiple systems, linking neural, immune, and metabolic function within the same mechanism.
How do these BH4-dependent pathway shifts specifically impact development and function?
The BH4 Shunt redirects activity across three BH4-dependent systems, and each one affects a different biological domain.
1. Neurotransmitter system (AAAH): Reduced BH4 availability shifts aromatic amino acid processing away from monoamine synthesis, lowering dopamine, serotonin, and melatonin, while increasing glutamate. This disrupts excitatory and inhibitory balance within cortico-striatal-thalamic-limbic circuits that regulate movement, habits, reward, and behavioral control, producing autism traits.
2. Ether-lipid metabolism (AGMO): Reduced ether-lipid breakdown alters stress-adaptive lipid signaling, including the endocannabinoid system and broader lipid balance. This changes how the body regulates adaptive responses across systems.
3. Nitric oxide and redox system (NOS): Increased oxidative stress activates redox-sensitive protein shifts that reallocate biological resources toward stress adaptation instead of typical development and maintenance. Over time, this produces cumulative strain, allostatic overload, and wear and tear, leading to comorbid conditions.
Because this stress state is driven by genetic and epigenetic factors, it remains active, creating a lifelong allostatic pattern that produces both autism traits and predictable comorbid clustering.
The specific autism and comorbidity phenotype depends on which regulatory stress systems are activated, when activation occurred during development, and how long it persists.
Trait Expression Questions
These questions explain how autism traits and comorbid traits emerge in the model, and why expression varies across individuals.
How do autism traits emerge in this model?
Autism traits emerge from altered neural development driven by shifts in BH4-dependent neurotransmitter pathways.
Reduced monoamine synthesis, including dopamine, serotonin, and melatonin, combined with increased glutamate production, disrupts excitatory and inhibitory balance within cortico-striatal-thalamic-limbic circuits. These circuits regulate movement, habit formation, reward processing, and behavioral control.
When these pathways are altered during critical developmental windows, neural circuit formation is affected. Because skills and behaviors are encoded within these circuits, this results in the observable traits associated with autism.
How do comorbid traits emerge in this model?
Comorbid traits emerge from sustained activation of regulatory system domains under a chronic stress-response state.
BH4-dependent shifts in nitric oxide signaling and redox balance activate redox-sensitive protein effectors, which reallocate biological resources toward stress adaptation rather than typical maintenance and repair. This alters function across systems including immune, metabolic, autonomic, and cellular repair processes.
Over time, persistent activation produces cumulative strain, instability, and wear, referred to as allostatic overload, resulting in comorbid conditions that cluster across regulatory systems.
Why do traits vary between individuals?
Variation occurs because stress-response activation is not uniform across individuals.
Different genetic and epigenetic factors influence which regulatory system domains are activated, which BH4-dependent pathways are most affected, and which redox-sensitive protein effectors are engaged. Activation can also vary in intensity, timing, and duration.
Because development is time-dependent and systems are interconnected, differences in when activation occurs and how long it persists produce distinct patterns of autism traits and comorbid trait clustering in each individual.
Model Development and Validation Questions
These questions explain how the model was built, what is established versus novel, and what level of validation currently supports the framework.
How was this model developed?
This model was constructed using raw biological data derived from existing research. A biochemical network of gene-coded proteins was built to map functional relationships across regulatory systems.
Autism biomarker data was then compared against this network to identify consistent patterns of dysregulation. This process revealed a structured biochemical cascade linking stress-response activation, BH4 pathway redirection, neural circuit disruption, and comorbidity clustering.
This approach identifies system-level structure within existing data rather than generating new experimental datasets.
What was already established in existing research?
Prior research had already established several relevant mechanisms, including oxidative stress, BH4-dependent pathway function, neurotransmitter imbalance, nitric oxide signaling, immune activation, metabolic disruption, and redox-sensitive protein regulation.
These findings were derived from experimental and clinical studies and represent the underlying biological data used in constructing the model.
However, they were studied across separate domains and were not previously organized into a unified framework explaining their interaction or co-occurrence.
What is novel about this model?
The novel contribution of this model lies in its structure, not in the discovery of individual mechanisms.
It organizes previously established biological findings into a unified biochemical cascade defined by four core pillars: stress-response activation, BH4 pathway redirection, neural circuit disruption, and comorbidity clustering.
This framework explains how autism traits and comorbid conditions emerge from the same upstream process through coordinated pathway shifts and system-level prioritization.
What parts of the model have been validated?
The model has received mechanistic validation at the level of its individual components and their relationships.
Beginning in 2025, emerging research has supported the mechanisms corresponding to each of the four pillars. This includes evidence consistent with stress-response activation, BH4 pathway shifts, neural circuit disruption, and system-level effects associated with comorbid conditions.
This validation reflects that the relationships described within the model are consistent with observed biological processes.
What has not yet been fully validated?
The complete system-level model has not yet been validated as a single integrated framework.
While individual mechanisms and their relationships are supported, full validation would require direct testing of the entire biochemical cascade operating together within the same system.
It is important to distinguish between validating individual mechanisms and validating a fully integrated systems-level model. However, in biochemical networks, validation of individual nodes and their interactions provides convergent support for the integrity of the overall system architecture.
How does this model compare to existing biomedical autism models?
Existing biomedical autism models have identified multiple relevant mechanisms, including oxidative stress, mitochondrial dysfunction, immune activation, metabolic disruption, and neurotransmitter imbalance. These findings are well-supported in the literature and are widely recognized as contributing to autism and related conditions.
However, these models typically examine these mechanisms either in isolation or as loosely connected contributors. Even when integrated frameworks are proposed, they generally describe associations between systems rather than defining a specific biochemical cascade that links them in a stepwise and testable structure.
For example, oxidative stress and mitochondrial dysfunction are consistently reported in autism, with evidence showing their interaction with immune signaling and neural development, but the precise organization of these interactions into a unified causal architecture remains unclear.
In contrast, this model was constructed by mapping raw biological data into a biochemical network and identifying how these mechanisms align within a defined sequence. It organizes previously established findings into four core pillars: stress-response activation, BH4 pathway redirection, neural circuit disruption, and comorbidity clustering.
The key distinction is that this framework defines a structured biochemical cascade that links autism traits and comorbid conditions through shared upstream processes, rather than treating them as parallel or loosely connected outcomes.
Where can I read the supporting research?
Supporting research is available through curated validation pages and primary source citations.
These include detailed breakdowns of validated mechanisms as well as direct links to the scientific literature supporting each component of the model.